4
Changes in Ownership
Cogent Biosciences, Inc. Filed Acc 0001104659-26-038057
Director sold 7,000,000 shares at $34.66 ($242,620,000)
- Director acquired 7,000,000 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Fairmount Funds Management LLC · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-31 | Conversion : show line 1 in the form | +7,000,000 | 12,503,418 | I | ||
| 2026-03-31 | Sale : show line 2 in the form | −7,000,000 | $34.66 | $242,620,000 | 5,503,418 | I |
| Open-market sales · 7,000,000 sh · avg $34.66 · $242,620,000 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-31 | Conversion : show line 3 in the form Series A Convertible Preferred Stock | −28,000 | 39,414 | I |
Loading xslF345X06/tm2610819-2_4seq1.xml…